Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(17%)
Results Posted
125%(5 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 33 (50.0%)

Trials by Status

recruiting117%
completed467%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

NCT07357831
completedphase_3

A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream

NCT03308799
terminatedphase_2

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects

NCT03819218
completedphase_3

This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream

NCT03802344
completedphase_1

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

NCT03758365
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07357831Phase 3

A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

Recruiting
NCT03308799Phase 3

A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream

Completed
NCT03819218Phase 2

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects

Terminated
NCT03802344Phase 3

This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream

Completed
NCT03758365Phase 1

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

Completed
NCT03462927Phase 2

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6